Literature DB >> 12377371

Efferent projections from the striatal patch compartment: anterograde degeneration after selective ablation of neurons expressing mu-opioid receptor in rats.

Hironobu Tokuno1, Satomi Chiken, Kiyokazu Kametani, Tetsuji Moriizumi.   

Abstract

Local injection of mu-opioid receptor specific neurotoxin, dermorphin-saporin, into the striatum resulted in selective degeneration of striatal neurons in the patch compartment. We analyzed subsequent anterograde degeneration of axons and terminals at light and electron microscopic level. Light microscopic examination after silver impregnation method revealed that degenerating axons and terminals arising from the striatal patch compartment were distributed in the globus pallidus, entopeduncular nucleus, and substantia nigra. They were found in both pars reticulata and compacta of the substantia nigra. Electron microscopic examination revealed that the degenerating axon terminals contained large pleomorphic vesicles and formed symmetric synapses on dendrites. The present results suggest that patch neurons expressing mu-opioid receptor send projection fibers to multiple nuclei of the basal ganglia.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12377371     DOI: 10.1016/s0304-3940(02)00837-6

Source DB:  PubMed          Journal:  Neurosci Lett        ISSN: 0304-3940            Impact factor:   3.046


  17 in total

1.  Lesions of the Patch Compartment of Dorsolateral Striatum Disrupt Stimulus-Response Learning.

Authors:  Terrell A Jenrette; Jordan B Logue; Kristen Ashley Horner
Journal:  Neuroscience       Date:  2019-07-26       Impact factor: 3.590

2.  Striatal patch compartment lesions alter methamphetamine-induced behavior and immediate early gene expression in the striatum, substantia nigra and frontal cortex.

Authors:  Ryan C Murray; Yamiece E Gilbert; Anna S Logan; John C Hebbard; Kristen A Horner
Journal:  Brain Struct Funct       Date:  2013-04-27       Impact factor: 3.270

Review 3.  Compartmental function and modulation of the striatum.

Authors:  Eric M Prager; Joshua L Plotkin
Journal:  J Neurosci Res       Date:  2019-09-05       Impact factor: 4.164

4.  Striatal patch compartment lesions reduce stereotypy following repeated cocaine administration.

Authors:  Ryan C Murray; Mary C Logan; Kristen A Horner
Journal:  Brain Res       Date:  2015-06-19       Impact factor: 3.252

5.  Blockade of patch-based μ opioid receptors in the striatum attenuates methamphetamine-induced conditioned place preference and reduces activation of the patch compartment.

Authors:  Kristen A Horner; Mary Caroline Logan; Trevor J Fisher; Jordan B Logue
Journal:  Eur J Pharmacol       Date:  2017-01-03       Impact factor: 4.432

6.  Partial ablation of mu-opioid receptor rich striosomes produces deficits on a motor-skill learning task.

Authors:  C Lawhorn; D M Smith; L L Brown
Journal:  Neuroscience       Date:  2009-05-20       Impact factor: 3.590

7.  Basal Ganglia disorders associated with imbalances in the striatal striosome and matrix compartments.

Authors:  Jill R Crittenden; Ann M Graybiel
Journal:  Front Neuroanat       Date:  2011-09-07       Impact factor: 3.856

8.  Conditional targeting of medium spiny neurons in the striatal matrix.

Authors:  Björn Reinius; Martina Blunder; Frances M Brett; Anders Eriksson; Kalicharan Patra; Jörgen Jonsson; Elena Jazin; Klas Kullander
Journal:  Front Behav Neurosci       Date:  2015-03-27       Impact factor: 3.558

9.  Response of striosomal opioid signaling to dopamine depletion in 6-hydroxydopamine-lesioned rat model of Parkinson's disease: a potential compensatory role.

Authors:  Hidetaka Koizumi; Ryoma Morigaki; Shinya Okita; Shinji Nagahiro; Ryuji Kaji; Masanori Nakagawa; Satoshi Goto
Journal:  Front Cell Neurosci       Date:  2013-05-17       Impact factor: 5.505

10.  Striatal pre-enkephalin overexpression improves Huntington's disease symptoms in the R6/2 mouse model of Huntington's disease.

Authors:  Stéphanie Bissonnette; Mylène Vaillancourt; Sébastien S Hébert; Guy Drolet; Pershia Samadi
Journal:  PLoS One       Date:  2013-09-11       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.